**Background**
The complement system is a critical component of the innate immune response, consisting of a cascade of proteins that enhance the ability of antibodies and phagocytic cells to clear pathogens from an organism. Central to this system is the C3 protein, which serves as a pivotal convergence point for all three complement activation pathways (classical, lectin, and alternative). Overactivation of the complement system is implicated in various inflammatory diseases and autoimmune disorders, making the inhibition of C3 a significant therapeutic strategy. Compstatin has been identified as a potent inhibitor of C3, effectively blocking the cleavage of C3 and subsequent downstream effector functions. To rigorously validate the biological effects of such inhibitors in experimental settings, the use of a non-functional analog is essential. In this context, we will introduce a negative control for Compstatin research – Compstatin control peptide.
**Definition**
Compstatin control peptide is a negative control of Compstatin, designed to lack the inhibitory activity against the complement system C3.
**Experimental Application**
The Compstatin control peptide is characterized by the sequence IAVVQDWGHHRAT-NH2, with a molecular weight of 1488.65 and a specific Compstatin control peptide Formula of C66H101N23O17. In biomedical research, this peptide is utilized to ensure that the observed inhibitory effects of Compstatin are due to its specific interaction with C3 rather than non-specific peptide effects. Researchers can refer to the Compstatin control peptide technical information to optimize their experimental design. When conducting studies, the Compstatin control peptide in vitro application allows for the comparison of C3 cleavage and activation markers between the active inhibitor and the control group. By maintaining high Compstatin control peptide purity, researchers can ensure the reliability of their data and the reproducibility of their results. In conclusion, Compstatin control peptide is an essential tool for the precise study of complement system inhibition.
Keywords
Compstatin control peptide, 301544-78-5, Complement System, Inhibitor, inhibitor, inhibit
References